These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 8245688)
1. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688 [TBL] [Abstract][Full Text] [Related]
2. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis. Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393 [TBL] [Abstract][Full Text] [Related]
3. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD. Zemel D; Betjes MG; Dinkla C; Struijk DG; Krediet RT Perit Dial Int; 1995; 15(2):134-41. PubMed ID: 7612733 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation. Zemel D; Krediet RT; Koomen GC; Kortekaas WM; Geertzen HG; ten Berge RJ Nephrol Dial Transplant; 1994; 9(2):169-74. PubMed ID: 8190331 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane. Zemel D; ten Berge RJ; Struijk DG; Bloemena E; Koomen GC; Krediet RT Clin Nephrol; 1992 Feb; 37(2):97-103. PubMed ID: 1551256 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis. Steinhauer HB; Schollmeyer P Kidney Int; 1986 Feb; 29(2):584-90. PubMed ID: 3457982 [TBL] [Abstract][Full Text] [Related]
7. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide? Douma CE; de Waart DR; Struijk DG; Krediet RT Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660 [TBL] [Abstract][Full Text] [Related]
8. Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis? Douma CE; de Waart DR; Struijk DG; Krediet RT J Lab Clin Med; 1998 Oct; 132(4):329-40. PubMed ID: 9794705 [TBL] [Abstract][Full Text] [Related]
9. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. Lin CY; Chen WP; Fu LW; Yang LY; Huang TP Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653 [TBL] [Abstract][Full Text] [Related]
10. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood. Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-8 in chronic renal failure and dialysis patients. Nakanishi I; Moutabarrik A; Okada N; Kitamura E; Hayashi A; Syouji T; Namiki M; Ishibashi M; Zaid D; Tsubakihara Y Nephrol Dial Transplant; 1994; 9(10):1435-42. PubMed ID: 7816257 [TBL] [Abstract][Full Text] [Related]
12. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship. Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642 [TBL] [Abstract][Full Text] [Related]
13. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis. Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158 [TBL] [Abstract][Full Text] [Related]
14. Nitrate in stable CAPD patients and during peritonitis. Douma CE; de Waart DR; Zemel D; Imholz AL; Koomen GC; Struijk DG; Krediet RT Adv Perit Dial; 1995; 11():36-40. PubMed ID: 8534733 [TBL] [Abstract][Full Text] [Related]
15. Stimulation of peritoneal synthesis of vasoactive prostaglandins during peritonitis in patients on continuous ambulatory peritoneal dialysis. Steinhauer HB; Günter B; Schollmeyer P Eur J Clin Invest; 1985 Feb; 15(1):1-5. PubMed ID: 3921379 [TBL] [Abstract][Full Text] [Related]
16. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis. Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719 [TBL] [Abstract][Full Text] [Related]
17. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency. Klínger J; Enríquez J; Arturo JA; Delgado M; Avila G; Ceballos O Adv Perit Dial; 2002; 18():170-6. PubMed ID: 12402613 [TBL] [Abstract][Full Text] [Related]
18. Peritoneal mesothelial cells produce inflammatory related cytokines. Yao V; Platell C; Hall JC ANZ J Surg; 2004 Nov; 74(11):997-1002. PubMed ID: 15550091 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response. Wang HH; Lin CY Am J Kidney Dis; 2005 Aug; 46(2):328-38. PubMed ID: 16112053 [TBL] [Abstract][Full Text] [Related]
20. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis? Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]